Sex‐specific effects of prenatal vitamin D supplementation on repetitive behaviour and neuroimmune mediators in the BTBR mouse model of autism spectrum disorders
Abstract Background and Purpose Autism spectrum disorders (ASDs) are prevalent in males compared with females, possibly attributed to male‐centric profiles diagnostic criteria. ASD pathogenesis involves neuroinflammation and altered immune signalling. Therefore, maternal vitamin D deficiency may contribute to ASD by impairing fetal neurodevelopment, promoting immune dysregulation and inflammatory conditions. Due to the difficult recruitment of the vulnerable paediatric population, we used BTBR T + tf/J (BTBR) male and female mice, characterized by core ASD‐like behaviours, to investigate the effects of prenatal vitamin D supplementation. Experimental Approach On gestational day 9, pregnant BTBR dams received a subcutaneous injection of either vitamin D 3 (400 ng·kg −1 ) or vehicle. At 8‐week‐old, offspring underwent a battery of behavioural tests, including Hole Board, Marble Burying, Self‐grooming, Open Field and Social Interaction tests. mRNA expression and protein levels of tumour necrosis factor‐α (TNF‐α), interleukin‐1β (IL‐1β), transforming growth factor‐β2 (TGF‐β2), fatty acid‐binding protein 4 (FABP4) and resistin in prefrontal cortex and hippocampus were then quantified. Key Results Maternal vitamin D supplementation reduced BTBR stereotypies. Moreover, vitamin D decreased cortical and hippocampal protein TNF‐α levels only in BTBR males. In addition, vitamin D upregulated hippocampal TGF‐β2 gene expression and FABP4 gene expression and protein content in male offspring, whereas a down‐regulation of TGF‐β2 mRNA and protein levels was reported in females. Conclusion and Implications Our findings indicated that prenatal vitamin D supplementation exerted beneficial effects on BTBR stereotypies, neuroinflammatory and neuroimmune signalling alterations, ultimately suggesting its potential as an early preventive strategy to target ASD sex‐tailored biomolecular dysfunctions.
Authors
- Maria Grazia Morgese (ORCID: https://orcid.org/0000-0002-9887-5504)
- Paolo Tucci (ORCID: https://orcid.org/0000-0001-7314-445X)
- Luigia Trabace (ORCID: https://orcid.org/0000-0003-3073-8404)
- Oreste Gualillo (ORCID: https://orcid.org/0000-0002-7154-1328)
- Stefania Schiavone (ORCID: https://orcid.org/0000-0002-1190-0659)
- Vladyslav Sikora (ORCID: https://orcid.org/0000-0002-4147-6879)
- María Bové (ORCID: https://orcid.org/0000-0001-8794-4247)
- Mariam Farrag (ORCID: https://orcid.org/0000-0001-6403-5999)
- Maria Adelaide Palmieri
- Rossella Pia Palmieri (ORCID: https://orcid.org/0009-0007-6603-1431)
Institutions
- University of Foggia (IT)
- Instituto de Investigación Sanitaria de Santiago (ES)
- Servicio Gallego de Salud (ES)
Publication Details
- Journal
- British Journal of Pharmacology
- Published
- 2026-11-15
- DOI
- https://doi.org/10.1111/bph.70721
- Primary Topic
- Autism Spectrum Disorder Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00